Companies/VN/IMP

IMEXPHARM CORPORATION

Income flow

Annual
IMP FINANCIAL-API Income StatementPeriod 2025-12-31Source FINANCIAL-API
Net sales$2441B+11% Y/YRevenue$2441B+11% Y/YGross profit$1002B+17% Y/YCost of revenue$1440BOperating profit$446B+10% Y/YOperating expenses$555BNet profit$349B+9% Y/YTax$97BOperating expenses$555B

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Capital & dividends

YieldTrailing twelve-month dividends as a percent of the current share price (income yield).1.62%5y avgAverage dividend yield over the past five years — a smoother view than the latest print.1.43%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).0PayoutShare of earnings paid out as dividends. Higher means more income returned; lower leaves more for reinvestment.0.0%Shares outTotal shares currently outstanding (issued and not retired).154.0MFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).1.5M
Dividend calendar
Ex-dividend
2026-07-13
Last cash
600 · 2026-07-13
Stock splits
  1. 2:12024-09-17
  2. 11:102024-07-11
  3. 105:1002023-10-05
  4. 13200:100002020-07-14
  5. 115:1002018-06-04
  6. 11:102017-05-24